Preconditioning with low doses of endotoxin has been shown to induce endotoxin hyporesponsiveness. The present study was designed to assess the metabolic response of various tissues during endotoxemia and after pretreatment with endotoxin.
Controlled experimental animal study.
Research laboratory of a university hospital.
Measurements and results.
Ten pigs were randomly assigned to a control (n = 5) or a treatment group (n = 5), the latter receiving incremental doses of endotoxin 5–2 days prior the experiments. Apart from hemodynamics and oxygen transport variables, lactate, glucose, and glycerol were measured in muscle, subcutaneous fat, and hepatic tissue using microdialysis. Endotoxin was infused (1 µg·kg·h) until the animals died. A significant increase in tissue lactate (eightfold) and glycerol (fivefold) was observed in the control animals. This effect was almost completely abolished in the endotoxin pretreated group. Endotoxin pretreatment had no significant effects on mean arterial pressure [56 (range 34–89) mmHg vs 70 (47–88) mmHg, n.s.] or cardiac output [4.8 (3.0–5.9) l/min vs 3.2 (2.1–4.2) l/min, n.s.], but significantly improved arterial pO2 and pH (P<0.05). Increase of oxygen extraction was higher in control animals [from 34% (range 24–47%) to 72% (range 61–79%)] compared to the pretreatment group [from 30% (range 22–42%) to 44% (range 34–50%), P<0.05]. Endotoxin pretreatment increased survival time from 5.3 h (5.0–5.8) to 8.0 h (7.0–8.5) (P<0.05), respectively.
Microdialysis monitoring revealed that endotoxin preconditioning ameliorates the increase in tissue metabolism during endotoxemia, accompanied by decreased systemic oxygen demand despite unchanged global hemodynamics.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Staubach KH, Jonas S, Kooistra A, Bruch HP (1996) Early endotoxin tolerance—a preventive concept against infection. Langenbecks Arch Chir Suppl Kongressbd 113:360–363
Ungerstedt U (1991) Microdialysis—principles and applications for studies in animals and man. J Intern Med 230:365–273
Rosdahl H, Hamrin K, Ungerstedt U, Henriksson J (1998) Metabolite levels in human skeletal muscle and adipose tissue studied with microdialysis at low perfusion flow. Am J Physiol 274:E936–945
Korth U, Merkel G, Fernandez FF, Jandewerth O, Dogan G, Koch T, van Ackern K, Weichel O, Klein J (2000) Tourniquet-induced changes of energy metabolism in human skeletal muscle monitored by microdialysis. Anesthesiology 93:1407–1412
He W, Fong Y, Marano MA, Gershenwald JE, Yurt RW, Moldawer LL, Lowry SF (1992) Tolerance to endotoxin prevents mortality in infected thermal injury: association with attenuated cytokine responses. J Infect Dis 165:859–864
West MA, Heagy W (2002) Endotoxin tolerance: a review. Crit Care Med 30:S64-S73
Mengozzi M, Ghezzi P (1993) Cytokine down-regulation in endotoxin tolerance. Eur Cytokine Network 4:89–98
Wolk K, Docke WD, von Baehr V, Volk HD, Sabat R (2000) Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood 96:218–223
Frankenberger M, Pechumer H, Ziegler-Heitbrock HW (1995) Interleukin-10 is upregulated in LPS tolerance. J Inflamm 45:56–63
Ziegler-Heitbrock HW (1995) Molecular mechanism in tolerance to lipopolysaccharide. J Inflamm 45:13–26
Wysocka M, Robertson S, Riemann H, Caamano J, Hunter C, Mackiewicz A, Montaner LJ, Trinchieri G, Karp CL (2001) IL-12 suppression during experimental endotoxin tolerance: dendritic cell loss and macrophage hyporesponsiveness. J Immunol 166:7504–7513
Hersch M, Gnidec AA, Bersten AD, Troster M, Rutledge FS, Sibbald WJ (1990) Histologic and ultrastructural changes in nonpulmonary organs during early hyperdynamic sepsis. Surgery 107:397–410
Humer MF, Phang PT, Friesen BP, Allard MF, Goddard CM, Walley KR (1996) Heterogeneity of gut capillary transit times and impaired gut oxygen extraction in endotoxemic pigs. J Appl Physiol 81:895–904
Oldner A, Goiny M, Ungerstedt U, Sollevi A (1996) Splanchnic homeostasis during endotoxin challenge in the pig as assessed by microdialysis and tonometry. Shock 6:188–193
Oldner A, Goiny M, Rudehill A, Ungerstedt U, Sollevi A (1999) Tissue hypoxanthine reflects gut vulnerability in porcine endotoxin shock. Crit Care Med 27:790–797
Woltmann A, Lebeau A, Staubach KH, Schade FU, Arnholdt H, Bruch HP (1994) Histomorphological changes of organs, in particular the liver, in a study of endotoxin tolerance in an animal model. Eur Surg Res 26:353–361
Ayuse T, Brienza N, Revelly JP, O'Donnell CP, Boitnott JK, Robotham JL (1995) Alternations in liver hemodynamics in an intact porcine model of endotoxin shock. Am J Physiol 268:H1106–1114
Stjernstrom H, Karlsson T, Ungerstedt U, Hillered L (1993) Chemical monitoring of intensive care patients using intravenous microdialysis. Intensive Care Med 19:423–428
Ungerstedt U (1997) Microdialysis—a new technique for monitoring local tissue events in the clinic. Acta Anaesthesiol Scand Suppl 110:123
Muller M (2002) Science, medicine, and the future: microdialysis. BMJ 324:588–591
Sibbald WJ, Messmer K, Fink MP (2000) Roundtable conference on tissue oxygenation in acute medicine, Brussels, Belgium, 14–16 March 1998. Intensive Care Med 26:780–791
Fink M (1997) Cytopathic hypoxia in sepsis. Acta Anaesthesiol Scand Suppl 110:87–95
Fink MP (2000) Cytopathic hypoxia. A concept to explain organ dysfunction in sepsis. Minerva Anestesiol 66:337–342
Fink MP (2001) Cytopathic hypoxia. Mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis. Crit Care Clin 17:219–237
Harada M, Okuda C, Sawa T, Fuse A, Imai H, Tanaka Y (1994) Changes in muscle and liver lactate concentrations after endotoxin infusion in rats. Circ Shock 43:166–170
An editorial regarding this article can be found in the same issue (http://dx.doi.org/10.1007/s00134-003-1692-4)
About this article
Cite this article
Klaus, S., Heringlake, M., Block, K. et al. Metabolic changes detected by microdialysis during endotoxin shock and after endotoxin preconditioning. Intensive Care Med 29, 634–641 (2003). https://doi.org/10.1007/s00134-002-1602-1
- Critical care
- Cellular metabolism